BioAdvance Ventures Fund Overview

  • Fund Strategy
  • Venture

  • Fund Status
  • Liquidated

  • Size

  • Vintage
  • 2005

Vintage

  • Dry Powder

BioAdvance Ventures Fund General Information

Description

BioAdvance Ventures Fund was an early-stage venture capital fund managed by Quaker Partners. The fund was located in Bala Cynwyd, Pennsylvania.

Contact Information

Fund Manager
Fund Manager Website
Fund Category
Venture Capital
Open Date
Native Currency
USD
Fund Manager's Location
  • 150 Monument Road
  • Suite 207
  • Bala Cynwyd, PA 19004
  • United States
+1 (267)
Fund Domiciles
United States: Delaware

BioAdvance Ventures Fund Investments (5)

BioAdvance Ventures Fund has made a total of 5 investments. Its most recent deal was a with Argintex for . The deal was made on 23-Oct-2008.

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Argintex 23-Oct-2008 Other Consumer Non-Durables Startup
Cellatope 02-Apr-2007 Diagnostic Equipment Startup
NuPathe 13-Sep-2006 Drug Delivery Product Development
Immune Control 01-Jun-2005 Early Stage VC (Series A) Drug Discovery Product Development
Protez Pharmaceuticals 17-Jun-2004 Early Stage VC (Series A) Pharmaceuticals Startup
To view BioAdvance Ventures Fund’s complete investments history, request access »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioAdvance Ventures Fund Investment Strategy

Investments by Industry

Investments by Deal Type

PitchBook helps you see a fund’s investments based on target industry, year and deal type—so you can quickly understand its strategy at a glance.

Request a free trial

BioAdvance Ventures Fund Limited Partners (3)

Cephalon is one of BioAdvance Ventures Fund’s 3 limited partners. Its latest Original was on 23-Sep-2004.

Limited Partner Name Type Status Commitment Date Commitment Type
Cephalon Former 23-Sep-2004 Original
GSK Current 23-Sep-2004 Original
Pension Plan of Independence Blue Cross Corporate Pension Former 23-Sep-2004 Original
To view BioAdvance Ventures Fund’s complete limited partners history, request access »

BioAdvance Ventures Fund Returns Data

The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.

IRR (%)

 

DPI (x)

 

RVPI (x)

 

TVPI (x)

 

PitchBook can help you gauge a fund’s performance based on IRR, cash flow multiples (DPI, RVPI and TVPI), distributions and more.

Request a free trial

BioAdvance Ventures Fund Returns History

Period Contribution (by all LPs) Dry Powder Distribution (to all LPs) NAV Total Fund Distr+NAV IRR DPI RVPI TVPI Dry Powder %

This information is available in the PitchBook Platform. To explore BioAdvance Ventures Fund‘s full profile, request access.

Request a free trial

BioAdvance Ventures Fund FAQs

  • What is BioAdvance Ventures Fund?

    BioAdvance Ventures Fund was an early-stage venture capital fund managed by Quaker Partners.

  • Who manages BioAdvance Ventures Fund?

    BioAdvance Ventures Fund is managed by Quaker Partners.

  • Where is BioAdvance Ventures Fund domiciled?

    BioAdvance Ventures Fund is domiciled in United States: Delaware.

  • What is BioAdvance Ventures Fund's size?

    BioAdvance Ventures Fund has a size of .

  • What type of fund is BioAdvance Ventures Fund?

    The fund type of BioAdvance Ventures Fund is Venture.

  • What is the status of BioAdvance Ventures Fund?

    BioAdvance Ventures Fund is liquidated.

  • What has BioAdvance Ventures Fund invested in?

    BioAdvance Ventures Fund has made numerous investments in companies like Argintex, Cellatope, and NuPathe within the Consumer Non-Durables, Diagnostic Equipment, and Drug Delivery industries.

  • What has BioAdvance Ventures Fund invested in recently?

    BioAdvance Ventures Fund's latest investment was on 23-Oct-2008 in Argintex, a company within the Consumer Non-Durables industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process